AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Mar 4, 2021
29821_dirs_2021-03-04_09114b99-a6a0-48e5-950d-42451162af0f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-03-02
Reporting Person: Brennan Daniel J. (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-02 | Common Stock | S | 9475.0000 | $38.8426 | Disposed | 275370.0000 | Direct |
| 2021-03-03 | Common Stock | S | 12127.0000 | $38.6886 | Disposed | 263243.0000 | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.66 to $38.95, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.558 to $38.90, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.